Selon l'agence d'information du Burkina (AIB), un éléphanteau de moins d'un an a été retrouvé dans les périphéries du quartier du Yiézan dans le département de Yaho, le dimanche 9 novembre 2025.
Alerté sur la situation, le service départemental des eaux et forêts s'est rendu sur les lieux pour constater et sécuriser le pachyderme.
L'animal a été retrouvé tout seul par des riverains s'aventurant vers les logements.
L'animal a été conduit dans une cour où la population s'est déportée massivement en visiteurs.
En effet, le département de Yaho est frontalier à la forêt du Grand-Balé où l'on trouve des troupeaux d'éléphants. Pour rappel, le Grand-Balé est une commune rurale située dans le département de Yaho dans la province des Balé, région de Bankui au Burkina.
Selon le témoignage de la population locale, les éléphants font souvent des incursions dans les champs, à la limite de la forêt.
L'éléphanteau a été mis sous protection par le service départemental des eaux et forêts, dirigé par le lieutenant Thomas Kombasséré.
Ce, en vue de prendre des mesures urgentes pour la survie de l'animal qui etait visiblement épuisé et affamé.
Cette situation intervient quelques mois après la découverte d'un éléphant (finalement abattu), au secteur 26 de la ville de Bobo-Dioulasso, dans la région du Guiriko. C'était en août 2025.
Lefaso.net
Source : AIB
Indigenous leaders at COP30 in Belem. They are demanding active participation in the negotiation process. Credit: Tanka Dhakal/IPS
By Tanka Dhakal
BELÉM, Brazil, Nov 11 2025 (IPS)
Indigenous leaders from across the Amazon region are calling on climate negotiators to base climate initiatives on the recognition of the land rights of affected Indigenous communities. From the COP30 venue in Belém, these leaders are demanding full participation in the design and implementation of proposed projects.
The Indigenous leaders presented evidence that reforestation initiatives, carbon market schemes, and renewable energy projects could displace Indigenous and local communities and harm ecosystems if they are developed without community involvement and respect for their rights. According to the UNFCCC assessment report, active participation of Indigenous and local communities is key to the success of climate change-related initiatives, whether funded by public or private sources.
In this context, IPS spoke with Elcio Severino da Silva Manchineri (also known as Toya Manchineri), an Indigenous leader from the Manchineri people of Brazil. Manchineri is the General Coordinator of the Coordination of Indigenous Organizations of the Brazilian Amazon (COIAB).
Elcio Severino da Silva Manchineri at COP30. Credit: Tanka Dhakal/IPS
IPS: COP30 is happening on the land of Indigenous people here in Belém. What is the call from the Indigenous community to the negotiators?
Toya: Our main request to negotiators is to include Indigenous land demarcation as a climate solution—recognizing Indigenous lands as a climate response strategy.
IPS: Why is the recognition of land rights for Indigenous communities in climate negotiations so important?
Toya: It’s important because 80 percent of biodiversity is found in Indigenous territories, which means we conserve life. Land titling here and in other countries is crucial. If countries want to meet their targets for zero deforestation, they need to title Indigenous lands.
IPS: What is your view on reforestation efforts that happen without negotiation with Indigenous communities?
Toya: Reforestation is one of the key issues. But really—who is going to take care of those forests? We are the ones who care for them. We will be responsible for those forests. It’s been proven that 98 percent of our territories are well preserved. So, the real issue behind reforestation is guaranteeing the rights of Indigenous peoples to ensure our survival as well.
IPS: My follow-up question is: how can Indigenous communities and climate finance or climate progress come together? Is there a way?
Toya: We are working on climate hack finance and direct access to climate finance. Only direct access will strengthen what people are already doing in their territories. At the heart of it is the question: how can climate finance support what we’re already doing? That’s the important part.
IPS: To gain direct access to finance, you might need a place at the negotiation table. Do you think there is space for Indigenous leaders like you?
Toya: No, I don’t have a place—and that’s the problem. We need countries to consider us as negotiators, as part of official delegations, because we are the ones who know how to care for the forest and the environment.
IPS: Since you don’t have a place at the negotiation table, but Indigenous people have the knowledge to mitigate and adapt to climate change, how can climate projects or negotiations integrate Indigenous knowledge? Is there a way for Indigenous communities, their knowledge, and the negotiation process to come together?
Toya: It’s not only our traditional knowledge that can help mitigate climate change—we can also influence scientific knowledge. Sometimes scientists think they’re the only ones who can speak, but we can too. Our lands capture large amounts of carbon, which helps clear the air and reduce emissions. That’s the knowledge and practice we bring.
IPS: Finally, is there anything you want to see come out of the Belém climate conference? What is your top agenda?
Toya: What we really want to see in the final document is countries recognizing land titling for Indigenous peoples as a climate strategy—as a climate mitigation strategy. The just transition needs clear timelines to be effective. It must be just, but we also need to know by when.
Note: This feature is published with the support of Open Society Foundations.
IPS UN Bureau Report
Follow @IPSNewsUNBureau
Excerpt:
Rakhi Matan holds bottles of cough syrup in her palm. This is what she gave to her kids two weeks back when they were feeling ill. Credit: Zofeen Ebrahim/IPS
By Zofeen Ebrahim
KARACHI, Pakistan, Nov 11 2025 (IPS)
When 23 children died in India’s Madhya Pradesh after consuming contaminated cough syrup in early September, the news barely registered across the border. In Pakistan—where self-medication is rampant and syrup bottles are household staples—the tragedy strikes dangerously close to home.
Many in Pakistan remain unaware that those sweet, over-the-counter syrups can be fatal. In the recent Indian case, the children—all under six—died of kidney failure after consuming syrup laced with diethylene glycol (DEG), a toxic solvent found at 500 times the permissible limit.
Investigations revealed the manufacturer, Sresan, had sourced industrial-grade propylene glycol from local chemical and paint dealers instead of certified pharmaceutical suppliers. With no qualified chemist overseeing production, the syrup went untested—and deadly.
This isn’t the first such incident. In 2022, Indian-made syrups caused the deaths of at least 70 children in The Gambia and 18 in Uzbekistan. Between December 2019 and January 2020, at least 12 children died in Indian-administered Kashmir after taking similarly contaminated syrup.
The prescribing doctor in India was the first to be arrested, followed by the suspension of the drug inspector and deputy director. The manufacturer, who had been absconding since September, has now been caught.
“It shows that even doctors can get caught in legal and ethical trouble, even when unaware of a drug’s quality issues,” said Professor Mishal Khan of the London School of Hygiene & Tropical Medicine. “The tragedy is a warning for Pakistan—weak regulation hurts everyone: doctors, pharma companies, and patients alike.”
A 2024 study by Khan found that approximately 40 percent of Karachi doctors accepted incentives in return for prescribing medicines from a fake pharmaceutical company without any checks on the company’s manufacturing standards or medicine quality. Antibiotics and cough syrups were among the medicines they agreed to promote.
As Pakistan enters its flu season, Karachi’s hospitals are filling up. “Between 50 to 70 percent of children who visit our clinics have respiratory tract infections,” said Dr. Wasim Jamalvi of Dr. Ruth K. M. Pfau, Civil Hospital Karachi.
And with the flu comes a predictable companion: cough syrup.
“If a child is brought for consultation for fever, cough and cold, parents feel a prescription is incomplete without a cough syrup,” said Dr. D.S. Akram, a senior pediatrician, who stopped prescribing them two decades ago. “Cough syrups don’t work—they just make the children drowsy or irritable,” she said.
Jamalvi agrees, “We don’t recommend syrups for under-fives, but parents still give them—they’re easily available over the counter.”
Self-Medication Culture
In Pakistan, cough syrups—often called sherbet—are viewed as harmless cures.
“I swear by this syrup a doctor gave me years ago,” said Mohammad Yusuf, a 31-year-old houseboy. “One spoon at night and I sleep better.”
Two weeks ago, when Rakhi Matan’s children, aged 10 and 13, came down with the flu, she reached for a bottle of leftover cough syrup from last year. “It saved me the doctor’s fee—he’d have prescribed the same thing,” she said.
Such casual self-medication is common—and hard to control.
Dr. Qaiser Sajjad, former secretary general of the Pakistan Medical Association, said regulating cough syrup sales is nearly impossible with thousands of quacks operating in the city. Medical store worker Majid Yusufzai agreed, admitting syrups are sold freely without prescriptions and “entire families share the same bottle.”
Health experts say Pakistan’s culture of self-prescription—reinforced by weak enforcement and cheap access to medicines—makes the system vulnerable to similar disasters.
Dr. Obaidullah Malik, heading the Drug Regulatory Authority of Pakistan (DRAP), told IPS that Pakistan imported the majority of the raw materials (for several drugs, including cough syrups) from India and China.
With over 100,000 drug manufacturing companies, India, referred to as the ‘pharmacy of the world,’ is known for affordable generic drugs. But recent deaths have cast a long shadow on its safety standards.
Tighter Drug Oversight
“It is of great concern,” said Malik, adding that scrutiny of domestic quality control was enhanced after it received a global alert from the WHO on October 13, of three substandard cough syrups manufactured in India.
“Thankfully, the contaminated syrups were never exported to Pakistan,” confirmed Malik. “There’s no evidence of illegal shipments either—but we’re staying vigilant to ensure a tragedy like India’s doesn’t happen here.”
“DRAP has made it mandatory for all pharmaceuticals, including herbal and nutraceutical manufacturers as well as importers, to pre-test additives such as glycerin, propylene glycol, and sorbitol—either in their own laboratories or through public sector facilities like the Central Drugs Laboratory (CDL) in Karachi or the 12 provincial drug testing,” said Malik. The authority is double-checking vendor credentials and certifications and instructed field teams to step up sampling and testing—both of raw materials coming in and the finished syrups.
Recently, it trained pharma company reps from Nepal, Gambia, Sierra Leone, Maldives, and Sri Lanka on a quick detection method called Thin Layer Chromatography (TLC), which helps spot contamination early—saving time, cutting costs, and improving safety checks nationwide.
There are between 700 and 800 pharmaceutical companies across Pakistan, but only about 300 are members of the Pakistan Pharmaceutical Manufacturers Association—leaving much of the industry operating with little oversight. Yet, despite its fledgling state compared to India’s, Pakistan’s pharma sector is eager to expand into global markets. Khan cautioned that the recent scandal over unsafe medicines could jeopardize those ambitions before they even take off.
To avoid a similar crisis and protect its reputation abroad, Pakistan’s regulator has stepped up oversight at home. “Since November 2023, DRAP has recalled 63 finished products contaminated with diethylene glycol (DEG) and ethylene glycol (EG), identified 44 impurities, and issued 13 alerts about contaminated raw materials,” said DRAP’s CEO.
As Karachi’s clinics continue to fill up this flu season, syrup bottles are flying off shelves—often with no pharmacist in sight. “It’s just a syrup,” said Yusuf. He does not know, but for dozens of families across the border, that sweet bottle brought irreversible loss.
IPS UN Bureau Report
Follow @IPSNewsUNBureau
Excerpt:
India’s cough syrup tragedy is a warning for Pakistan, where self-medication is common and the sweet cure fills every home. Experts call for tighter safety checks.